Summary:
It is generally assumed that busulphan/cyclophoshamide (Bu/Cy)-based conditioning regimens for haematopoietic stem cell transplantation (SCT) do not affect growth. We evaluated growth and endocrine function after Bu/Cy-based conditioning in 64 children without a history of irradiation. Mean height standard deviation scores remained stable, but unexplained disturbances of growth after SCT were found in 17/48 (35%) of the children without growth-limiting disorders (10/23 in patients treated for haematological malignancies). In 10 patients, growth hormone (GH) secretion status was evaluated, and insufficient GH secretion was diagnosed in four patients. Thyroid function was evaluable in 52 patients. Two developed antibody-mediated thyroid disorders and 10 (19%) compensated primary hypothyroidism. Gonadal function was evaluable in 21 patients and was normal in all seven patients treated with low-dose Bu (8 mg/kg), whereas seven of the 14 children receiving high-dose Bu (16–20 mg/kg) developed gonadal failure; the majority of these patients had not been exposed to gonadotoxic therapy prior to Bu/Cy. Of the 49 evaluable patients, 16 developed subclinical hyperparathyroidism. We conclude that, besides gonadal and thyroid dysfunction, impaired growth and hyperparathyroidism often occur after Bu/Cy conditioning for SCT and that growth impairment may be the result of insufficient GH secretion.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Giorgiani G, Bozzola M, Locatelli F et al. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 1995; 86: 825–831.
Shankar SM, Bunin NJ, Moshang T . Growth in children undergoing bone marrow transplantation after busulfan and cyclophosphamide conditioning. J Pediatr Hematol Oncol 1996; 18: 366.
Michel G, Socié G, Gebhard F et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: The impact of conditioning regimen without total-body irradiation: a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 1997; 15: 2238–2246.
Cohen A, Rovelli A, Bakker B et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects – EBMT. Blood 1999; 93: 4109–4115.
Afify Z, Shaw PJ, Clavano-Harding A, Cowell CT . Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant 2000; 25: 1087–1092.
Fredriks AM, van Buuren S, Burgmeijer RJ et al. Continuing positive secular growth change in The Netherlands 1955–1997. Pediatr Res 2000; 47: 316–323.
Albertsson-Wikland K, Rosberg S . Physiological GH secretion: changes with age, stature and puberty. In: Savage MO, Bourguignon JP, Grossman AB (eds.). Frontiers in Paediatric Neuroendocrinology. Blackwell Science Ltd.: Boston, MA, 1994; pp 131–137.
Jansson C, Boguszewski C, Rosberg S et al. Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein. Clin Chem 1997; 43: 950–956.
Rikken B, van Doorn J, Ringeling A et al. Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Horm Res 1998; 50: 166–176.
Bercu BB, Diamond Jr FB . Growth hormone neurosecretory dysfunction. Clin Endocrinol Metab 1986; 15: 537–590.
Albertsson-Wikland K, Lannering B, Marky I et al. A longitudinal study on growth and spontaneous growth hormone (GH) secretion in children with irradiated brain tumors. Acta Paediatr Scand 1987; 76: 966–973.
Darzy KH, Shalet SM . Radiation-induced growth hormone deficiency. Horm Res 2003; 59: 1–11.
Brennan BM, Shalet SM . Endocrine late effects after bone marrow transplant. Br J Haematol 2002; 118: 58–66.
Toubert ME, Socie G, Gluckman E et al. Short- and long-term follow-up of thyroid dysfunction after allogeneic bone marrow transplantation without the use of preparative total body irradiation. Br J Haematol 1997; 98: 453–457.
Kami M, Tanaka Y, Chiba S et al. Thyroid function after bone marrow transplantation: possible association between immune-mediated thyrotoxicosis and hypothyroidism. Transplantation 2001; 71: 406–411.
Al Fiar FZ, Colwill R, Lipton JH et al. Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants. Bone Marrow Transplant 1997; 19: 1019–1022.
Tauchmanova L, Selleri C, Rosa GD et al. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer 2002; 95: 1076–1084.
Sarafoglou K, Boulad F, Gillio A, Sklar C . Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 1997; 130: 210–216.
Bakker B, Massa GG, Oostdijk W et al. Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies. Eur J Pediatr 2000; 159: 31–37.
Couto-Silva AC, Trivin C, Thibaud E et al. Factors affecting gonadal function after bone marrow transplantation during childhood. Bone Marrow Transplant 2001; 28: 67–75.
DeSanctis V, Galimberti M, Lucarelli G et al. Gonadal function after allogenic bone marrow transplantation for thalassaemia. Arch Dis Child 1991; 66: 517–520.
Sanders JE . Growth and development after hematopoietic cell transplantation. In: Thomas ED, Blume KG, Forman SJ (eds.). Hematopoietic Cell Transplantation. Blackwell Science Inc.: Malden, MA, 1999; pp 764–775.
Byrne J, Fears TR, Gail MH et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 1992; 166: 788–793.
Schneider AB, Gierlowski TC, Shore-Freedman E et al. Dose–response relationships for radiation-induced hyperparathyroidism. J Clin Endocrinol Metab 1995; 80: 254–257.
Acknowledgements
This work was sponsored by a grant from NWO, The Netherlands' Organization for Scientific Research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bakker, B., Oostdijk, W., Bresters, D. et al. Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplant 33, 1049–1056 (2004). https://doi.org/10.1038/sj.bmt.1704481
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704481
Keywords
This article is cited by
-
Characteristics and clinical course of thyroid abnormalities arisen in long term survivors of childhood cancer
BMC Pediatrics (2023)
-
Late endocrine effects after hematopoietic stem cell transplantation in children with nonmalignant diseases
Bone Marrow Transplantation (2022)
-
Body mass index at diagnosis of a childhood brain tumor; a reflection of hypothalamic-pituitary dysfunction or lifestyle?
Supportive Care in Cancer (2022)
-
The use of recombinant human growth hormone in patients with Mucopolysaccharidoses and growth hormone deficiency: a case series
Italian Journal of Pediatrics (2019)
-
Dynamics of fertility impairment and recovery after allogeneic haematopoietic stem cell transplantation in childhood and adolescence: results from a longitudinal study
Journal of Cancer Research and Clinical Oncology (2015)